Mesalazine and Rifaximin in Symptomatic Uncomplicated Diverticular Disease

被引：0
|
作者：
Festi, Davide [1 ]
Colecchia, Antonio [1 ]
机构：
[1] Univ Bologna, Dept Clin Med, I-40138 Bologna, Italy
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2009年 / 104卷 / 02期
关键词：
D O I：
10.1038/ajg.2008.53
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：532 / 532
页数：1
相关论文
共 50 条
  • [21] Effects of rifaximin-resistant Bifidobacterium longum W11 in subjects with symptomatic uncomplicated diverticular disease treated with rifaximin.
    Di Pierro, Francesco
    Bertuccioli, Alexander
    Pane, Marco
    Ivaldi, Leandro
    MINERVA GASTROENTEROLOGICA E DIETOLOGICA, 2019, 65 (04) : 259 - 264
  • [22] Neurite outgrowth in symptomatic uncomplicated diverticular disease
    De Simone, Veronica
    van Baarle, Lies
    Matteoli, Gianluca
    NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31 (09):
  • [23] Symptomatic uncomplicated diverticular disease: a critical appraisal
    Ritieni, Camilla
    Sbarigia, Caterina
    Scalamonti, Silvia
    Annibale, Bruno
    Carabotti, Marilia
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 18 (07) : 315 - 323
  • [24] RISKS FACTORS IN SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE
    Gioia, A.
    Schiro, G.
    Corrado, C.
    Rollo, N.
    Severi, C.
    DIGESTIVE AND LIVER DISEASE, 2021, 53 : S120 - S120
  • [25] Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease
    Colecchia, Antonio
    Vestito, Amanda
    Pasqui, Francesca
    Mazzella, Giuseppe
    Roda, Enrico
    Pistoia, Francesca
    Brandimarte, Giovanni
    Festi, Davide
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (02) : 264 - 269
  • [26] General practitioners' management of symptomatic uncomplicated diverticular disease of the colon by using rifaximin, a non-adsorbable antibiotic
    De Bastiani, R.
    Sanna, G.
    Bertolusso, L.
    Casella, G.
    De Polo, M.
    Zamparella, M.
    Cottone, C.
    Tosetti, C.
    Mancuso, M.
    Pirrotta, E.
    Lanzarotto, L.
    Napoli, L.
    De Bastiani, M.
    Disclafani, G.
    Gambaro, P.
    Scoglio, R.
    Belvedere, A.
    Fasulo, S.
    D'Urso, M.
    Benedetto, E.
    Baldi, E.
    Marchesan, F.
    Abagnale, G.
    Turnava, L.
    Salome, E.
    Ingravalle, F.
    Tursi, A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (01) : 423 - 430
  • [27] Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic,uncomplicated colonic diverticular disease
    Antonio Colecchia
    Amanda Vestito
    Francesca Pasqui
    Giuseppe Mazzella
    Enrico Roda
    Francesca Pistoia
    Giovanni Brandimarte
    Davide Festi
    World Journal of Gastroenterology, 2007, (02) : 264 - 269
  • [28] Treatment with rifaximin, mesalazin and lactobacillus GG in symptomatic diverticular disease
    Brini, C.
    Pontone, S.
    Garau, L.
    Pontone, P.
    Proceedings of the Second Joint Meeting European Council of Coloproctology: First National Congress Italian Society of Colo-Rectal Surgery, 2005, : 57 - 57
  • [29] MECHANISTIC RANDOMISED CONTROL TRIAL OF MESALAZINE IN SYMPTOMATIC DIVERTICULAR DISEASE
    Smith, J.
    Humes, D.
    Garsed, K.
    Lam, C.
    Zaitoun, A.
    Bennett, A.
    Scholefield, J.
    Spiller, R.
    GUT, 2012, 61 : A51 - A52
  • [30] Prucalopride for the Treatment of Symptomatic Uncomplicated Diverticular Disease of the Colon
    Tursi, Antonio
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2016, 50 (04) : 351 - 351
12345